![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 40, 37242-37253, October 4, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
§,
, and
**
From the In the absence of cyclic nucleotides, the
cAMP-dependent protein kinase and
cGMP-dependent protein kinases (cGKs) suppress phosphotransfer activity at the catalytic cleft by competitive inhibition of substrate binding with a pseudosubstrate sequence within
the holoenzyme. The magnitude of inhibition can be diminished by
autophosphorylation near this pseudosubstrate sequence. Activation of
type I cGK (cGKI) and type II cGK (cGKII) are differentially regulated
by their cyclic nucleotide-binding sites. To address the possibility
that the distinct activation mechanisms of cGKII and cGKI result from
differences in the autophosphorylation of the inhibitory domain, we
investigated the effects of autophosphorylation on the kinetics of
activation. Unlike the type I cGKs (cGKI
Neuroscience Graduate Program, the
¶ School of Public Health, the
Department of Biological
Chemistry, and the ** Mental Health Research Institute,
University of Michigan, Ann Arbor, Michigan 48104
and I
), cGKII
autophosphorylation did not alter the basal activity, nor the
sensitivity of the enzyme to cyclic nucleotide activation. To determine
residues responsible for autoinhibition of cGKII, Ala was substituted
for basic residues (Lys122, Arg118, and
Arg119) or a hydrophobic residue
(Val125) within the putative pseudosubstrate domain of
cGKII. The integrity of these residues was essential for full cGKII
autoinhibition. Furthermore, a cGKII truncation mutant containing this
autoinhibitory region demonstrated a nanomolar IC50 toward
a constitutively active form of cGKII. Finally, we present evidence
that the dominant negative properties of this truncation mutant are
specific to cGKII when compared with cAMP-dependent protein
kinase C
and cGKI
. These findings extend the known differences in
the activation mechanisms among cGK isoforms and allow the design of an
isoform-specific cGKII inhibitor.
To whom correspondence should be addressed: C560 MSRB II, 1150 West Medical Center, University of Michigan, Ann Arbor, MI 48109-0669. Tel.: 734-647-3172; Fax: 734-936-2690; E-mail:
muhler@umich.edu.
This article has been cited by other articles:
![]() |
A. B. Vaandrager, B. M. Hogema, M. Edixhoven, C. M. M. van den Burg, A. G. M. Bot, P. Klatt, P. Ruth, F. Hofmann, J. Van Damme, J. Vandekerckhove, et al. Autophosphorylation of cGMP-dependent Protein Kinase Type II J. Biol. Chem., August 1, 2003; 278(31): 28651 - 28658. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Hou, J. Lascola, N. O. Dulin, R. D. Ye, and D. D. Browning Activation of cGMP-dependent Protein Kinase by Protein Kinase C J. Biol. Chem., May 2, 2003; 278(19): 16706 - 16712. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |